Home
 /
Papers
 /
Genetics
 /
A unified genetic perturbation language for human cellular programming
Preprint
Open access
V1
Top 1% · Validated by QED

A unified genetic perturbation language for human cellular programming

Austin Hartman, Oliver Takacsi-Nagy, Courtney Kernick +18 more
November 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.11.20.689421
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genetics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By unifying previously incompatible perturbation classes into a single programmable language, CRISPR-All unlocks combinatorial genome-scale screening in primary human cells, revealing synergistic genetic programs—including enhanced CAR-T cell states—unreachable by any single perturbation approach.

QED claims analysis

Summary

CRISPR-All establishes a unified genetic perturbation language that enables simultaneous programming of gene knockouts, knockdowns, overexpression, and synthetic gene integration through a standardized molecular architecture, revealing that combinatorial perturbations across perturbation classes provide additive functional improvements in primary human cells that are inaccessible through individual perturbations and can be systematically discovered through genome-scale pooled screening with single-cell resolution.

See full analysis
Main Claim 1 –

Iterative scarless architecture enables arbitrary DNA element assembly

Supporting evidence

  • Standardized architecture expresses five elements at >95% efficiency
Main Claim 2 –

Optimized Pol II mRNA effectors act only in edited cells

Supporting evidence

  • mRNA architecture multiplexes four gene knockouts with maintained selectivity
  • mRNA architecture supports efficient, selective shRNA knockdown
Main Claim 3 –

Unified syntax enables interoperable Gene, Domain, KO, KD functions

Main Claim 4 –

CRISPR-All enables simultaneous head-to-head screening across perturbation classes

Supporting evidence

  • Meta-analysis yields 636 targets across six perturbation classes
  • Individual assays validate pooled CRISPR-All hits across classes

Abstract

Evolution simultaneously and combinatorially explores complex genetic changes across perturbation classes, including gene knockouts, knockdowns, overexpression, and the creation of new genes from existing domains. Separate technologies are capable of genetic perturbations at scale in human cells, but these methods are largely mutually incompatible. Here we present CRISPR-All, a unified genetic perturbation language for programming of any major type of genetic perturbation simultaneously, in any combination, at genome scale, in primary human cells. This is enabled by a standardized molecular architecture for each major perturbation class, development of a functional syntax for combining arbitrary numbers of elements across classes, and linkage to unique single cell compatible barcodes. To facilitate use, CRISPR-All converts high level descriptions of desired complex genetic changes into a single DNA sequence that can rewire genomic programs within a cell. Using the CRISPR-All language allowed for head-to-head functional comparisons across perturbation types in a comprehensive analysis of all previously identified genetic enhancements of human CAR-T cells. Combining CRISPR-All programs with single cell RNA sequencing revealed a greater diversity of phenotypic states, including improved functional performance, only accessible through distinct perturbation classes. Finally, CRISPR-All combinatorial genome scale screening of up to four distinct perturbations simultaneously revealed additive functional improvements in human T cells accessible only through iterative multiplexing of modifications across perturbation classes. CRISPR-All enables exploration of a combinatorial genetic perturbation space, which may be impactful for biological and clinical applications.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?